Bausch Health Companies (BHCN) Ratios
Bausch Health Companies Ratios
MX:BHCN's free cash flow for Q3 2026 was $750.77M. For the 2026 fiscal year, MX:BHCN's free cash flow was decreased by $-66.90M and operating cash flow was $817.67M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.47 | 0.86 | 1.30 | 1.08 | 1.08 |
| Quick Ratio | 1.08 | 0.62 | 0.94 | 0.80 | 0.89 |
| Cash Ratio | 0.32 | 0.17 | 0.22 | 0.14 | 0.11 |
| Solvency Ratio | 0.05 | 0.05 | 0.02 | 0.05 | 0.02 |
| Operating Cash Flow Ratio | 0.33 | 0.24 | 0.24 | -0.18 | 0.27 |
| Short-Term Operating Cash Flow Coverage | 4.65 | 0.60 | 2.29 | -1.69 | 0.00 |
| Net Current Asset Value | $ -19.80B | $ -21.07B | $ -21.84B | $ -21.18B | $ -23.63B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.81 | 0.81 | 0.82 | 0.81 | 0.78 |
| Debt-to-Equity Ratio | -38.35 | -16.90 | -21.91 | -30.01 | -213.72 |
| Debt-to-Capital Ratio | 1.03 | 1.06 | 1.05 | 1.03 | 1.00 |
| Long-Term Debt-to-Capital Ratio | 1.03 | 1.07 | 1.05 | 1.04 | 1.00 |
| Financial Leverage Ratio | -47.59 | -20.74 | -26.76 | -37.12 | -275.49 |
| Debt Service Coverage Ratio | 1.64 | 0.64 | 1.11 | 1.47 | 2.35 |
| Interest Coverage Ratio | 1.35 | 1.11 | 0.73 | 0.94 | 0.85 |
| Debt to Market Cap | 8.17 | 7.27 | 7.66 | 9.15 | 2.29 |
| Interest Debt Per Share | 61.61 | 62.51 | 64.99 | 61.41 | 67.09 |
| Net Debt to EBITDA | 5.80 | 7.24 | 9.74 | 7.02 | 6.77 |
| Profitability Margins | |||||
| Gross Profit Margin | 60.90% | 71.10% | 70.78% | 70.90% | 71.61% |
| EBIT Margin | 21.28% | 16.16% | 10.71% | 16.43% | 4.77% |
| EBITDA Margin | 32.85% | 29.32% | 25.15% | 35.43% | 38.65% |
| Operating Profit Margin | 21.28% | 16.06% | 11.00% | 16.86% | 14.35% |
| Pretax Profit Margin | 3.57% | 1.74% | -4.45% | -1.59% | -12.14% |
| Net Profit Margin | 1.53% | -0.48% | -6.76% | -2.61% | -11.11% |
| Continuous Operations Profit Margin | 1.17% | -0.75% | -6.98% | -2.61% | -11.11% |
| Net Income Per EBT | 42.78% | -27.54% | 151.79% | 164.34% | 91.50% |
| EBT Per EBIT | 16.80% | 10.80% | -40.50% | -9.42% | -84.63% |
| Return on Assets (ROA) | 0.61% | -0.17% | -2.16% | -0.83% | -3.21% |
| Return on Equity (ROE) | -28.89% | 3.60% | 57.93% | 30.64% | 883.96% |
| Return on Capital Employed (ROCE) | 10.04% | 7.82% | 4.18% | 6.30% | 5.04% |
| Return on Invested Capital (ROIC) | 3.24% | -2.96% | 4.09% | 6.16% | 4.60% |
| Return on Tangible Assets | 1.53% | -0.47% | -6.10% | -2.54% | -9.56% |
| Earnings Yield | 6.21% | -1.55% | -20.24% | -9.34% | -9.45% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.45 | 4.50 | 4.38 | 4.54 | 4.75 |
| Payables Turnover | 6.82 | 4.24 | 3.56 | 4.54 | 5.88 |
| Inventory Turnover | 2.51 | 1.74 | 1.66 | 2.17 | 2.41 |
| Fixed Asset Turnover | 5.05 | 5.41 | 4.63 | 5.08 | 5.28 |
| Asset Turnover | 0.40 | 0.36 | 0.32 | 0.32 | 0.29 |
| Working Capital Turnover Ratio | 20.99 | 60.92 | 10.95 | 22.72 | 20.13 |
| Cash Conversion Cycle | 173.79 | 204.35 | 200.95 | 168.28 | 166.16 |
| Days of Sales Outstanding | 82.00 | 81.15 | 83.28 | 80.42 | 76.82 |
| Days of Inventory Outstanding | 145.31 | 209.26 | 220.23 | 168.30 | 151.40 |
| Days of Payables Outstanding | 53.52 | 86.07 | 102.55 | 80.44 | 62.05 |
| Operating Cycle | 227.31 | 290.42 | 303.51 | 248.72 | 228.21 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 3.72 | 4.34 | 2.83 | -2.01 | 3.97 |
| Free Cash Flow Per Share | 2.63 | 3.42 | 2.08 | -2.75 | 3.18 |
| Dividend Paid and CapEx Coverage Ratio | 3.41 | 4.70 | 3.79 | -2.72 | 5.04 |
| Capital Expenditure Coverage Ratio | 3.41 | 4.70 | 3.79 | -2.72 | 5.04 |
| Operating Cash Flow Coverage Ratio | 0.07 | 0.07 | 0.05 | -0.04 | 0.06 |
| Operating Cash Flow to Sales Ratio | 0.13 | 0.17 | 0.12 | -0.09 | 0.17 |
| Free Cash Flow Yield | 37.87% | 42.30% | 25.99% | -43.88% | 11.53% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 16.14 | -64.60 | -4.94 | -10.71 | -10.58 |
| Price-to-Sales (P/S) Ratio | 0.25 | 0.31 | 0.33 | 0.28 | 1.18 |
| Price-to-Book (P/B) Ratio | -4.65 | -2.32 | -2.86 | -3.28 | -93.53 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 2.64 | 2.36 | 3.85 | -2.28 | 8.67 |
| Price-to-Operating Cash Flow Ratio | 1.87 | 1.86 | 2.83 | -3.12 | 6.95 |
| Price-to-Earnings Growth (PEG) Ratio | -0.04 | 0.70 | -0.03 | 0.14 | -0.16 |
| Enterprise Value Multiple | 6.55 | 8.29 | 11.07 | 7.81 | 9.81 |
| Enterprise Value | 22.46B | 23.41B | 24.37B | 22.47B | 31.99B |
| EV to EBITDA | 6.55 | 8.29 | 11.07 | 7.81 | 9.81 |
| EV to Sales | 2.15 | 2.43 | 2.78 | 2.77 | 3.79 |
| EV to Free Cash Flow | 23.04 | 18.62 | 32.06 | -22.56 | 27.98 |
| EV to Operating Cash Flow | 16.29 | 14.66 | 23.61 | -30.87 | 22.43 |
| Tangible Book Value Per Share | -41.81 | -46.09 | -48.56 | -47.20 | -54.16 |
| Shareholders’ Equity Per Share | -1.49 | -3.48 | -2.80 | -1.91 | -0.30 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.67 | 1.43 | -0.57 | -0.64 | 0.08 |
| Revenue Per Share | 28.16 | 26.15 | 24.00 | 22.44 | 23.50 |
| Net Income Per Share | 0.43 | -0.13 | -1.62 | -0.59 | -2.61 |
| Tax Burden | 0.43 | -0.28 | 1.52 | 1.64 | 0.92 |
| Interest Burden | 0.17 | 0.11 | -0.42 | -0.10 | -2.55 |
| Research & Development to Revenue | 0.06 | 0.06 | 0.07 | 0.07 | 0.06 |
| SG&A to Revenue | 0.33 | 0.34 | 0.26 | 0.26 | 0.25 |
| Stock-Based Compensation to Revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Income Quality | 11.49 | -22.18 | -1.69 | 3.43 | -1.52 |
Currency in USD
